Dr Ahmed Eltinay
MBBS, MRCP, FRCR
Consultant Clinical Oncologist
Languages spoken
English, Arabic
Expert in
Urological and upper gastrointestinal cancers
Overview
Dr Ahmed Eltinay is a Consultant Clinical Oncologist specialising in the treatment of urological and upper gastrointestinal cancers, including prostate, liver, bladder, kidney, pancreatic, and oesophageal cancers.
He completed his Clinical Oncology training at Oxford University Hospitals and the Royal Berkshire Hospital before being appointed as a Consultant Clinical Oncologist at the Royal Berkshire Hospital.
Dr Eltinay has been actively involved in a number of national and international clinical trials. He has authored several publications in peer-reviewed journals and also served as a reviewer for an international journal.
I believe that patient care should be individualised, as every patient has unique needs, circumstances, and goals. I am committed to ensuring that patients fully understand their condition and feel empowered to take an active role in decisions about their treatment. Building trust through clear communication and shared decision-making is central to my practice. Above all, I prioritise my patients' best interests and strive to be a dedicated advocate for them throughout their healthcare journey, providing support, guidance, and compassionate care every step of the way.
Clinical and research interests
Stereotactic ablative radiotherapy (SABR) for prostate cancer, oligoprogressive and oligometastatic disease
Professional memberships
- Member of the Royal College of Physicians (MRCP(UK))
- Fellow of the Royal College of Radiologists (FRCR), Clinical Oncology
- Educational Commission for Foreign Medical Graduates (ECFMG) certified
Publications & affiliations
Assessment of Suitability of PRV Margins Applied to Organs at Risk in Pancreatic Stereotactic Body Radiotherapy. Poster presentation at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting, 2025.
Management Approaches in WHO Grade III (Malignant) Meningioma and Haemangiopericytoma: A NOTCH (National Oncology Trainees' Collaborative for Healthcare Research) UK Multicentre Case Series. Poster presentation at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting, 2022.
Safety of Outpatient Management of Cancer Patients at Risk of Neutropenic Sepsis Using the MASCC Score at Norfolk and Norwich University Hospital (NNUH). National Cancer Research Institute (NCRI). Poster presentation at Norfolk and Norwich University Hospital, 2018.
Eltinay ATEO and Freebairn AJ. Abscopal Effect of Radiation on Liver Metastases of Poorly Differentiated Parotid Carcinoma. JCO Precision Oncology. 2022;6. doi:10.1200/PO.22.00146.
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.